Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The JAK-STAT pathway at 30: Much learned, much more to do
Rachael L. Philips, Yuxin Wang, HyeonJoo Cheon, et al.
Cell (2022) Vol. 185, Iss. 21, pp. 3857-3876
Open Access | Times Cited: 372

Showing 1-25 of 372 citing articles:

Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 402
Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 195
TGF-β signaling in health, disease and therapeutics
Ziqin Deng, Tao Fan, Xiao Chu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 181
Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease
Jonggeol Jeffrey Kim, Dan Vitale, Diego Véliz Otani, et al.
Nature Genetics (2023) Vol. 56, Iss. 1, pp. 27-36
Open Access | Times Cited: 77
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
Pavel Kolkhir, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 743-767
Closed Access | Times Cited: 64
Strategies to therapeutically modulate cytokine action
Warren J. Leonard, Jian‐Xin Lin
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 10, pp. 827-854
Closed Access | Times Cited: 56
Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story
Michael Bonelli, Andreas Kerschbaumer, Kastriot Kastrati, et al.
Annals of the Rheumatic Diseases (2023) Vol. 83, Iss. 2, pp. 139-160
Open Access | Times Cited: 47
Deucravacitinib is an allosteric TYK2 protein kinase inhibitor FDA-approved for the treatment of psoriasis
Robert Roskoski
Pharmacological Research (2023) Vol. 189, pp. 106642-106642
Open Access | Times Cited: 45
Sensory neurons promote immune homeostasis in the lung
Masato Tamari, Kate L. Del Bel, Aaron Ver Heul, et al.
Cell (2023) Vol. 187, Iss. 1, pp. 44-61.e17
Open Access | Times Cited: 43
JAK inhibitors for rheumatoid arthritis
Satoshi Kubo, Shingo Nakayamada, Yoshiya Tanaka
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 4, pp. 333-344
Closed Access | Times Cited: 42
Interferon- γ and infectious diseases: Lessons and prospects
Jean‐Laurent Casanova, John D. MacMicking, Carl Nathan
Science (2024) Vol. 384, Iss. 6693
Closed Access | Times Cited: 42
The intrinsic substrate specificity of the human tyrosine kinome
Tomer M. Yaron, Brian A. Joughin, Emily M. Huntsman, et al.
Nature (2024) Vol. 629, Iss. 8014, pp. 1174-1181
Open Access | Times Cited: 38
JAK-STAT signaling maintains homeostasis in T cells and macrophages
Nikolaus Fortelny, Matthias Farlik, Victoria Fife-Gernedl, et al.
Nature Immunology (2024) Vol. 25, Iss. 5, pp. 847-859
Open Access | Times Cited: 24
IL6-STAT3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma
Zhengyang Hu, Qihai Sui, Xing Jin, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 23
JAK/STAT in leukemia: a clinical update
Dong Liang, Qiao-Li Wang, Wenbiao Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 21
Emerging Roles of Macrophage Polarization in Osteoarthritis: Mechanisms and Therapeutic Strategies
Z. L. Yuan, Jiang De-cheng, Mengzhu Yang, et al.
Orthopaedic Surgery (2024) Vol. 16, Iss. 3, pp. 532-550
Open Access | Times Cited: 20
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Invasion and metastasis in cancer: molecular insights and therapeutic targets
Yongxing Li, Fengshuo Liu, Qingjin Cai, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
The ins and outs of innate and adaptive type 2 immunity
Ari B. Molofsky, Richard M. Locksley
Immunity (2023) Vol. 56, Iss. 4, pp. 704-722
Open Access | Times Cited: 35
The role of Janus kinase signaling in the pathology of atopic dermatitis
Emma Guttman‐Yassky, Alan D. Irvine, Patrick M. Brunner, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 6, pp. 1394-1404
Open Access | Times Cited: 34
Variant STAT4 and Response to Ruxolitinib in an Autoinflammatory Syndrome
Hratch Baghdassarian, Sarah A. Blackstone, Gwendolyn Clay, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 24, pp. 2241-2252
Open Access | Times Cited: 33
The safety of systemic Janus kinase inhibitors in atopic dermatitis: A systematic review and meta‐analysis of randomized controlled trials
Sanghyuk Yoon, Kihun Kim, Kihyuk Shin, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 1, pp. 52-61
Closed Access | Times Cited: 33
Insect-pathogen crosstalk and the cellular-molecular mechanisms of insect immunity: uncovering the underlying signaling pathways and immune regulatory function of non-coding RNAs
Deepak Kumar Mahanta, Tanmaya Kumar Bhoi, J. Komal, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 30
Structural basis of Janus kinase trans-activation
Nathanael A. Caveney, Robert A. Saxton, Deepa Waghray, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112201-112201
Open Access | Times Cited: 28
Inhibition of T-cell activity in alopecia areata: recent developments and new directions
Thierry Passeron, Brett King, Julien Séneschal, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top